Trial intelligence / Profile preview

Ritalin and Physiological Stress During Exercise in ADHD

NCT02704546Unknown

Sponsor
Sheba Medical Center
Start
Apr 2016
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Sheba Medical Center. Primary endpoints: Physiological strain at 2 days and Aerobic capacity at 2 days. Status: unknown.

02

Drugs

methylphenidate hydrochloride extended-release chewable tablet
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT02704546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02704546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call